Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for April 14th

Read MoreHide Full Article

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 14th:

Boise Cascade Company (BCC - Free Report) : This company that manufactures wood products and distributes building materials carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Boise Cascade has a PEG ratio of 0.97 compared with 1.07 for the industry. The company possesses a Growth Score of A.

 

Boise Cascade Company PEG Ratio (TTM)

Boise Cascade, L.L.C. PEG Ratio (TTM)

Boise Cascade Company peg-ratio-ttm | Boise Cascade Company Quote

 

Universal Electronics Inc. (UEIC - Free Report) : This pre-programmed and universal control products, audio-video accessories, and intelligent wireless security and smart home products manufacturer and seller that carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.

 

Universal Electronics has a PEG ratio of 0.87, compared with 1.47 for the industry. The company possesses a Growth Score of A.

 

Repsol, S.A. (REPYY - Free Report) : This integrated energy company that carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 48.9% over the last 60 days.

 

Repsol, S.A. Price and Consensus

Repsol SA Price and Consensus

Repsol, S.A. price-consensus-chart | Repsol, S.A. Quote

 

Repsol has a PEG ratio of 0.23, compared with 1.02 for the industry. The company possesses a Growth Score of B.

 

Repsol, S.A. PEG Ratio (TTM)

Repsol SA PEG Ratio (TTM)

Repsol, S.A. peg-ratio-ttm | Repsol, S.A. Quote

 

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Universal Electronics Inc. (UEIC) - free report >>

Repsol SA (REPYY) - free report >>

Boise Cascade, L.L.C. (BCC) - free report >>